Jubilant Pharmova News: Read Latest News & Live Updates on Jubilant Pharmova, Photos, Videos at CNBCTV18.com

homeJubilant Pharmova News

Jubilant Pharmova NEWS

All

market | Apr 18, 2024 5:22 AM IST
Jubilant Pharmova to get its US generics business back to profitability through these measures
market | Jan 28, 2024 4:55 PM IST
Jubilant Pharma to sell entire stake in Sofie Biosciences for $139.43 million
earnings | Oct 27, 2023 4:07 PM IST
Jubilant Pharmova Q2 Results | Profit spikes 1,057% to ₹62 crore, revenue up 5%
market | May 30, 2023 12:32 PM IST
Jubilant Pharmova's Canada unit gets OAI status, Hari Bhartia to step down as Managing Director
market | May 30, 2023 10:38 AM IST
Jubilant Pharmova shares fall as much as 11% after impairment charges drag drugmaker to Q4 loss
market | Mar 17, 2023 12:18 PM IST
Jubilant Pharmova gains most in over two years after Canadian-arm gets loan for capacity expansion
business | Feb 3, 2023 7:25 PM IST
Jubilant Pharmova Q3 Result: Multiple issues lead to net loss, margin drops 450 basis points
market | Dec 28, 2022 11:37 AM IST
The three factors that keep this brokerage bullish on Jubilant Pharmova
market | Dec 14, 2022 4:29 PM IST
Jubilant Pharmova gains after USFDA completes inspection of its Nanjangud facility with eight observations
market | Oct 31, 2022 11:02 AM IST
Jubilant Pharmova shares climb despite Roorkee unit getting OAI status from USFDA
market | Aug 29, 2022 11:59 AM IST
Here's why Jubilant Pharmova is bucking the trend in a weak market
market | Jul 16, 2021 10:06 AM IST
Macquarie cuts target price on Jubilant Pharmova, here’s why
healthcare | Jul 15, 2021 3:00 PM IST
USFDA places Jubilant Pharmova's Roorke facility under import alert
market | Jun 21, 2021 4:51 PM IST
Motilal Oswal maintains 'buy' on Jubilant Pharmova, here’s why
business | Mar 19, 2021 12:19 PM IST
Jubilant Ingrevia lists on the bourses today

Jubilant Pharmova NEWS

Jubilant Pharmova to get its US generics business back to profitability through these measures

Jubilant Pharma to sell entire stake in Sofie Biosciences for $139.43 million

Jubilant Pharmova Q2 Results | Profit spikes 1,057% to ₹62 crore, revenue up 5%

Jubilant Pharmova's Canada unit gets OAI status, Hari Bhartia to step down as Managing Director

Jubilant Pharmova shares fall as much as 11% after impairment charges drag drugmaker to Q4 loss

Jubilant Pharmova gains most in over two years after Canadian-arm gets loan for capacity expansion

Jubilant Pharmova Q3 Result: Multiple issues lead to net loss, margin drops 450 basis points

The three factors that keep this brokerage bullish on Jubilant Pharmova

Jubilant Pharmova gains after USFDA completes inspection of its Nanjangud facility with eight observations

Jubilant Pharmova shares climb despite Roorkee unit getting OAI status from USFDA

Here's why Jubilant Pharmova is bucking the trend in a weak market

Macquarie cuts target price on Jubilant Pharmova, here’s why

USFDA places Jubilant Pharmova's Roorke facility under import alert

Motilal Oswal maintains 'buy' on Jubilant Pharmova, here’s why

Jubilant Ingrevia lists on the bourses today